Other specified malignant neoplasms of bronchus or lung ICD11 code: 2C75.Y
Parenteral > General injections > IV: 200 mg in vial powder for injection ; 1 g in vial powder for injection
EML status history
Adolescents and adults
The recommendation is for this specific medicine
Patents have expired in most jurisdictions
Read more about patents.
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, gemcitabine was added to the complementary list of the EML for use in treatment protocols for non-small cell lung cancer. The relevant extract from TRS994 regarding the Expert Committee's consideration of treatment protocols for non-small cell lung cancer is attached.